The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

FDA approves Journavx, a non-opioid medication for moderate to severe acute pain. Learn about its efficacy and side effects.

An arrest warrant has been issued for a New York doctor indicted by a Louisiana grand jury for allegedly prescribing an ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Through my understanding of sleep physiology and the latest scientific research, I have dramatically improved my sleep. I use ...

Md. - CuriosityStream Inc. (NASDAQ:CURI), a global factual entertainment company, has raised its upcoming dividend by 20%, bringing the yield to 4.59%, signaling confidence in its financial ...

By Jamal Lewis Click here for updates on this story January 31, 2025 (Houston Style Magazine) -- An influx of new residents in ...

Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...